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Background: The main objective of the present study is to evaluate the effects and possible benefits with regard to 
the postoperative period of lower third molar extractions, comparing the intraalveolar application of a bioadhesive 
gel of 0.2% chlorhexidine (CHX) to the use of a mouthwash with a super-oxidized solution, (SOS) Dermacyn® 
Wound Care (Oculus Innovative Sciences lnc., California, USA). 
Material and Methods: A randomized double-blind study was carried out in 20 patients with a split-mouth design, 
with a total of 40 extractions of symmetrically impacted bilateral lower third molars. Patients were divided into 
two groups, a control group (C = 20) and an experimental group (D = 20). Any infectious complications, wound 
healing, plaque accumulation in the stitches, and presence of trismus and inflammation were evaluated using 
the distance between different facial points, at three, eight, and fifteen days after extraction. Pain, swelling, and 
amount of analgesics taken were evaluated using the VAS scale throughout the 15 days following extraction. Tol-
erance to treatment was evaluated using a verbal scale. Results were statistically compared using the Student’s 
t- and chi-squared tests.
Results: No statistically significant differences were found between the two groups with regard to infectious com-
plications, swelling, or wound healing. Use of analgesics and self-reported pain levels were slightly lower in the 
experimental group than in the control group during days 6 and 7 of the study (p < 0.05). The global treatment 
tolerance was satisfactory and similar in both groups.
Conclusions: Both CHX and SOS are effective at improving the postoperative period after extraction of lower 
third molars.
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Introduction
Surgical extraction of the third molars is the most com-
mon procedure in oral surgery given the high incidence 
of dysodontiasis observed in these teeth (1). These 
procedures generally involve significant postoperative 
changes that are part of the surgical intervention and 
therefore are not considered complications (2). Never-
theless, many published studies seek to minimize these 
effects in order to obtain more rapid wound healing 
(3,4). 
Different studies state that the intensity of swelling and 
pain during the postoperative period of these interven-
tions is one of the most important factors when evaluat-
ing patients’ satisfaction and perception of the surgical 
treatment received (5). 
Clinical conditions linked to extraction of the lower 
third molars such as pain, swelling, and trismus have 
been observed (6). Complications such as alveolar oste-
itis, hematomas, and damage to nearby teeth or nerves 
have also been reported (7). 
Various studies in the literature evaluate different thera-
peutic protocols to improve the postoperative period af-
ter extraction of the lower third molars by integrating or 
modifying different aspects: use of preoperative antibi-
otics, different flap designs, osteotomies using high- or 
low-speed instruments, healing by either first or second 
intention, use of ice during the postoperative period, 
and use of corticosteroids (both via systemic and oral 
administration) (8-11). 
Wound healing is a physiological process through 
which the loss of integrity of the oral mucosa is recuper-
ated and damaged tissues are repaired. Without proper 
wound healing, bacteria greatly increase the risk of 
fibrinolysis, swelling, and poor wound healing, which 
result from infections in the extraction site. The most 
effective method for decreasing the risk of infection lo-
cally is the use of topical or systemic agents that can 
help to eliminate oral bacteria (12).
Chlorhexidine is one of the pharmaceuticals most of-
ten used for this purpose. It is an antiseptic designed to 
reduce dental plaque and oral bacteria, and it has been 
shown to have an immediate bactericidal effect as well 
as long-term bacteriostatic action (13).
When administered in vivo, chlorhexidine has been 
shown to have antibacterial properties more immediate 
than those of other antiseptics used in the oral cavity. 
Numerous studies support its use, whether topically or 
by applying a gel, in the improvement of wound healing 
(2,4,14).
Dermacyn Wound Care (DWC, Oculus Innovative Sci-
ences Netherlands BV, Sittard, Netherlands) is a su-
per-oxidized solution (SOS) that has proved useful in 
preventing infection at the level of the bone and sur-
rounding soft tissues, thereby facilitating and improv-
ing wound healing (15-18). 
The active components of this solution are 99.98% 
super-oxidized water and less than 0.02% of different 
reactive species of chlorine and oxygen, including hy-
pochlorous acid, sodium hypochlorite, sodium chloride, 
ozone, and chlorine dioxide. It should be notice that the 
total content of free chlorine available is low, ranging 
between 50–80 ppm. A SOS has bactericidal, virucidal, 
fungicidal, and sporicidal effects, and it is ready for use 
without further dilution or mixing. Moreover, it does 
not require manipulation or special disposal, and it has 
a shelf life of over 12 months (17, 20).
This study aims to assess the effects of chlorhexidine gel 
(CHX) and the SOS, applying the former on the wound 
surface after extraction of the lower third molars, with 
the latter being administered via a mouthwash during 
the postoperative period. The assessed factors were 
pain levels, wound healing, and postoperative swelling. 
Material and Methods
A randomized double-blind prospective study was car-
ried out in 20 patients with a split-mouth design). There-
fore, a total of 40 symmetrically impacted third molars 
were extracted. Patients were randomly divided into a 
control group (C = 20) and an experimental group (D = 
20). The study recruitment period lasted from January 
to December 2016. Randomization was carried out for 
the first third molar of each patient using the website 
https://www.random.org/lists/. The second third molar 
of each patient was automatically assigned to the other 
group (Fig. 1).
Prior to extraction, the difficulty level was assessed us-
ing the Koerner scale, with the inclusion criteria for the 
present study necessitating a difficulty level from be-
tween 5-7, inclusively (21).
The exclusion criteria for the present study were: pa-
tients with any contraindications to surgery, immu-
nocompromised patients, pregnant or breastfeeding 
women, women currently taking oral contraceptives, 
patients with allergies to chlorhexidine, lidocaine or 
paracetamol, patients who required the extraction of 
both third molars at the same time, presence of any type 
of bone pathology, and patients who had used antibiot-
ics, anti-inflammatories, or analgesics within four days 
prior to surgery.
As initial variables, data such as gender, age, smoking 
habits, medical history, reason for extraction, and as-
sessed difficulty level were recorded using the Koerner 
scale and a preoperative panoramic radiography (21).
Furthermore, the facial perimeter was measured during 
the preoperative period in order to give a better idea of 
the level of swelling observed after surgery. These mea-
surements included the distance in millimeters from the 
inner corner (canthus) of the eye (OAT) to the outermost 
part of the ear (tragus) and from the labial commissure 
to the tragus (ComAT). The maximum mouth opening 
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Fig. 1. Flow chart of the study.
was also measured as the distance between the upper 
and lower incisal edges in millimeters. 
During surgery, the total procedure time was recorded 
in minutes; any intraoperative complications were also 
recorded.
All of the extractions were performed by the same 
dentist in accordance with the surgical protocol used 
in this type of intervention (12). After finishing the ex-
tractions, a single dose of 0.2% chlorhexidine was ad-
ministered to the socket before placing the suture (4-0 
silk), or the SOS mouthwash was provided to the patient 
with enough for them to perform three rinses per day 
after brushing for one week. Patients were also provid-
ed a document with all postoperative instructions and 
the dates for follow-up appointments. A postoperative 
treatment of 400 g of ibuprofen every 8 hours for seven 
days was planned for both groups. 
A different dentist, who was unaware of which treat-
ment had been applied, performed the follow-up ap-
pointments of the patients. Infectious complications 
were measured on the third, eighth and fifteenth days, 
applying the criteria suggested in previous studies by 
our team (2,4), in addition to wound healing (wound 
consistency and appearance were categorized as good, 
acceptable, or bad (12), the presence of plaque on the 
surgical stitches (yes/no), and the maximum trismus, 
OAT and ComAT (following the same methodology 
used for the preoperative phase). Each patient recorded 
their levels of pain and swelling each day using a visual 
analog scale (VAS) from 0 to 10 throughout the 15-day 
follow-up period. Patients also made note of any res-
cue analgesics they needed to take. At the end of the 
study, the patients were asked to rate their tolerance to 
the treatment using a verbal scale. 
For the sample calculation, a 95% level of confidence 
and 80% level of statistical power were used to identify 
a difference of 1 in the values of the VAS scale used 
to assess pain and/or swelling, assuming a variance of 
1.25. In this way, the sample size was determined as 20 
patients per group. 
The data were included in a SPSS (IBM, USA) table 
for statistical analysis. The Kolmogorov-Smirnov test 
was used to measure data normality. The results of 
both groups were compared with the Student’s t-test for 
quantitative data and with the chi-squared test for all 
qualitative data.
The study was approved by the Ethics Committee of the 
University of Seville in Spain (CEI CODE: 2014PI7091), 
in accordance with the principles of the Helsinki Decla-
ration. All patients received a document prior to surgery 
that described the study, signing their written informed 
consent to take part in the study and to undergo surgery. 
Results
The distribution of the initial variables was homoge-
neous in both groups, as all patients belonged to both 
the control and experimental groups. In the group that 
used CHX (C), 8 lower left third molars and 12 lower 
right third molars were extracted. In the SOS group (D), 
12 lower left third molars and 8 lower right third molars 
were extracted. All patients complied with the set pro-
tocol. The mean age was 29.60 years ± 9.17. The studied 
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sample consisted of 16 women and 4 men, with 5 smok-
ers and 15 non-smokers. 
Similarly, with regard to the intraoperative variables, the 
difficulty level of the lower third molars (Koerner scale) 
(21) selected was similar in both groups (5.35 ± 0.97 in the 
CHX group and 5.42 ± 0.86 using the Koerner scale of 0 
to 10). The average procedure time of all surgeries was 
17.45 minutes ± 4.94, and therefore no statistically sig-
nificant differences were found between the two groups. 
No statistically significant findings were observed dur-
ing the follow-up appointment on the third day with 
regard to infectious complications (no infections were 
observed), wound healing during the postoperative pe-
riod (all values were “good”), or plaque accumulation 
on the surgical stitches (no plaque was detected in any 
patient). The OAT, ComAT and incidence and severity 
of trismus were similar in both groups (Table 1).
On the eighth day an infectious complication with pus 
on the wound was observed when the suture was re-
moved in both groups, with these wounds being sub-
sequently treated as a result. The wound healing rate 
and presence of plaque on the sutures were similar in 
both groups; only two patients in each group showed 
“regular” wound healing. In the chlorhexidine group, 
two surgical stitches were observed to have plaque ac-
cumulation, with five patients in the Dermacyn®, or 
SOS, group exhibiting plaque accumulation. The OAT, 
ComAT and trismus values were similar between both 
groups, without finding any significant differences (Ta-
ble 1). The last follow-up appointment took place fif-
teen days after surgery, with no significant differences 



















Trismus max  
(mm) 
C 0/20 1 (20)  1 (20) 81,80 ± 7,06 125,10 ± 13,65 40,85 ± 8,74 
D 0/20 1 (20) 1 (20) 82,15 ± 6,65 125,20 ± 13,32 40,65 ± 7,86 
















Trismus max  
(mm) 
C 1/19 1 (18) – 2 (2) 1 (12) – 2 (8) 81,20 ± 5,80 114,10 ± 9,91 44,25 ± 7,36 
D 1/19 1 (18) – 2 (2) 1 (15) – 2 (5) 81,50 ± 5,34 115,50 ± 7,59 44,10 ± 6,84 
















Trismus max  
(mm) 
C 0/20 1 (20) - 80,85 ± 7,08 110,05 ± 6,11 46,15 ± 6,80 
D 0/20 1 (20) - 81,30 ± 7,20 111,85 ± 6,39 45,20 ± 5,50 
p NS NS - NS NS NS 
Table 1. Data from the variables measured in the postoperative period: incidence of infectious complications; wound healing (possible val-
ues: 1, good; 2, regular; 3, bad); plaque accumulation on the surgical stitches (possible values: 1, yes; 2, no); OAT (distance in millimeters 
from the inner corner (canthus) of the eye to the outermost part of the ear) (mm); ComAT (distance in millimeters the labial commissure to 
the tragus ) (mm), and maximum trismus (mm) ; C Clorhexidine group ; D Dermacyn group) ; NS Non-significant difference; Y Yes ; N No.
With regard to postoperative pain during the 15 days’ 
follow-up period, the data showed that this was slightly 
lower in the experimental group (Dermacyn® or SOS) 
than in the control group (chlorhexidine) throughout 
the entire study. However, this difference was signifi-
cant only on the first, sixth and seventh days (Table 2, 
Fig. 2a). The swelling was also lower in the experimen-
tal group than in the control group during the entirety 
of the follow-up period, but no statistically significant 
differences were found between both groups (Table 2, 
Fig. 2b). The data regarding rescue medication provid-
ed similar results; need for rescue medication was al-
ways lower in the experimental group when compared 
with the control group. However, significant differ-
ences between both groups were observed on the sixth 
and seventh day (Table 2, Fig. 2c). The total treatment 
tolerance was satisfactory and similar in both groups.
Discussion
When performing oral surgery, numerous types of oral 
antiseptics can be use as adjuvants. They are used to 
encourage tissue healing and obtain better postopera-
tive results. Such antiseptics can be found in different 
compositions and different routes of administration. It 
is important to evaluate the different effects of adminis-
tering these solutions either before or after the surgery, 
as well as with regard to the type of solution and route 
of administration.
Mouthwashes and gels are the most commonly used and 
requested by both clinicians and patients. They are used 
to decrease the microbial load in the oral cavity and can 
be used before or after oral or periodontal surgery (22).
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P NS NS NS NS NS NS NS NS NS NS NS NS NS NS NS 
Use of recue 
drugs  
(units) 
Group D1 D2 D3 D4 D5 D6 D7 D8 D9 D10 D11 D12 D13 D14 D15 






























































































Table 2. Data on pain and swelling (ranked from 0 to 10 using a VAS scale) and use of rescue drugs during the studied postoperative period. C 
Clorhexidine group; D Dermacyn group ; D1 to D15 Day 1 to day 15 of follorw-up; NS Non-significant difference; Y Yes ; N No ; VAS Visual 
analogic scale.
Fig. 2. a) Pain during the 15-day postoperative period. C = Chlorhexidine group, D = Dermacyn® group; b) Swelling during the 15-days 
postoperative period. C = Chlorhexidine group, D = Dermacyn® group; c) Use of rescue medication during the 15-day postoperative period. 
C = Chlorhexidine group, D= Demarcyn® group.
Numerous scientific studies have shown that mouth-
washes containing chlorhexidine digluconate (CHX) 
which have antibacterial properties and reduce bacteria 
in the oral epithelium (4,23,24). 
Various microorganisms, such as Actinomyces naeslun-
dii, Veillonella dispar, Prevotella nigrescens, and Strep-
tococcus are highly susceptible to chlorhexidine (25).
Chlorhexidine in gel form allows it to be placed inside 
the socket, providing a more direct and long-term action 
when compared with chlorhexidine mouthwash, which 
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is applied superficially. Other studies have assessed the 
intraalveolar application of CHX gel during the intraop-
erative period, which seems to decrease the incidence 
of alveolitis, or dry socket, after extraction of the lower 
third molars, even in patients with coagulation disor-
ders (6,8,9,26).
No clinical trials have been published to date that are 
similar to the present study, in which a SOS was used 
in oral surgery. However, there are studies with expe-
rience using this solution as an adjuvant treatment to 
manage postoperative wounds of diabetic foot osteo-
myelitis in patients with a high risk of amputation. The 
majority of them conclude that the use of SOS as an 
adjuvant treatment in the postoperative is safe and can 
even eradicate the infection in the bone and surround-
ing soft tissues when combined with antibiotic therapy. 
However, authors agree that more studies are needed to 
confirm this (15,17,18). 
Other studies have explored the use of SOS in avoiding 
postoperative infections, even in literature reviews con-
ducted by Cochrane (20). 
Therefore, since no other studies in the field of oral sur-
gery have used a SOS, the present study carried out the 
first comparison of this compound with the gold stan-
dard used in these situations, chlorhexidine. Multiple 
studies can support this affirmation that chlorhexidine 
is the gold standard (27,28).
Osunde et al. carried out a study in 100 patients, apply-
ing a hot saline solution in the control group and 0.12% 
chlorhexidine mouthwash in the experimental group. 
The authors did not find statistically significant differ-
ences between the use of hot saline solution and 0.12% 
chlorhexidine mouthwash with regard to the develop-
ment of alveolar osteitis in patients who had undergone 
third lower molar extraction (27).
Kaur et al. performed a prospective double-blind study 
with a total of 300 impacted molars in 150 patients. In 
the study group, the combination of metronidazole with 
chlorhexidine gel was introduced. In the study group, 
the incidence of alveolitis was significantly reduced, 
from 22.6% to 6.6% (p ≤ 0.001); therefore, they con-
cluded that the intraalveolar use of this gel decreases 
the incidence of adverse reactions and complications 
related to the extraction of lower third molars (28).
In the present study, the study sample is adequate. 
Moreover, the study design makes the distribution of all 
variables exact in both groups, as all patients are classi-
fied as both control and experimental at the same time. 
In other words, the distribution of gender, age, allergies, 
and habits are similar in both groups. Likewise, it has 
been confirmed that the difficulty level of the third mo-
lars selected (Koerner scale) is similar, and the same in-
dividual belongs to the control and study group, which 
makes for a homogeneous sample.
The data collected in this study confirm that the treat-
ment with a SOS shows at least the same results as the 
CHX group with regard to infectious complications, 
swelling, pain, healing, and need for rescue medica-
tion. Our graphics show that the group treated with a 
SSO is ahead of the CHX group. While it is true that 
such differences are small and over a short period of 
time, and therefore of limited clinical significance, even 
with a sample of 40 extractions, differences in pain and 
analgesic consumption were observed on days 6 and 7, 
matching the end of the postoperative period. It could 
be concluded that the recovery is slightly better and 
quicker with a SSO than with CHX.
Regarding mouth opening and pain, no significant dif-
ferences were observed. None of the side effects re-
ported by other similar studies were observed, and no 
complications arose (6,12,29).
The antiseptic activity of the compound, as well as 
its low toxicity, may have influenced the results of the 
study, as both characteristics are below other antiseptics 
such as Betadine, which has been assessed in other re-
cent published studies (30).
Given the minimal clinical difference in the use of these 
antiseptics, it would be interesting to increase the num-
ber of studies and sample size to evaluate other second-
ary variables, such as the occurrence of specific side ef-
fects, as well as to include the economic cost evaluation 
of the product in order to provide a broader assessment 
of both pharmacological presentations. 
In conclusion, it can be said that the data of the pres-
ent study support that the use of 0.2% chlorhexidine gel 
and the super-oxidized solution Dermacyn® is effective 
and efficient in improving postoperative healing after 
extraction of the lower third molars.
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